Amneal Pharmaceuticals, Inc. AMRX Affordable Medicines — Currency translation
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s affordable medicines — currency translation.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s affordable medicines — currency translation?
- Amneal Pharmaceuticals, Inc. (AMRX) reported affordable medicines — currency translation of -$1.67M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s affordable medicines — currency translation changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s affordable medicines — currency translation decreased by 2837.7% year-over-year, from $61K to -$1.67M.
- What does affordable medicines — currency translation mean?
- Captures the financial impact of fluctuations in foreign exchange rates on the reported earnings of the Affordable Medicines segment. This metric highlights the sensitivity of the segment's international operations to global currency volatility.